A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Abacavir (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Innovation Pharmaceuticals
- 15 Mar 2018 According to an Innovation Pharmaceuticals media release, topline data from this trial is expected in Q2 2018.
- 21 Dec 2017 According to an Innovation Pharmaceuticals media release, topline data from this trial are expected to be released in the first quarter of 2018.
- 21 Dec 2017 According to an Innovation Pharmaceuticals media release, status changed from active, no longer recruiting to completed.